Home›Search›Expert Review of Anticancer Therapy

Expert Review of Anticancer Therapy

Taylor and Francis Ltd. · United Kingdom · Est. 1962

ISSN1473-7140eISSN1744-8328

SJR Q2✓ WOS SCIE✓ Scopus / SJR

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 50% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.84

H-Indexi

SNIPi

0.676

Total Worksi

3,732

Total Citationsi

73,328

2yr Mean Citednessi

2.24

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

Subject areas: Oncology; Pharmacology (medical).

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1962

FrequencyMonthly, 2006-

StatusActive (last: 2026)

Total Publications3,732

Publisher OrgTaylor & Francis

Visit Journal Website

Submission Info

Peer Review—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/11 · 55%

✅

Do you know the journal / publisher?

Taylor and Francis Ltd.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1473-7140 / 1744-8328

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

1.9k

2019

156

2020

104

1.5k

2021

117

1.1k

2022

115

1.1k

2023

118

592

2024

187

452

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

OncologyQ2

Pharmacology (medical)Q2

Subject Classification

Web of Science Categories

Oncology

Scopus Categories

Pharmacology (medical)Oncology

Research Topics (OpenAlex)

Lung Cancer Treatments and MutationsCancer Immunotherapy and BiomarkersBladder and Urothelial Cancer TreatmentsRenal cell carcinoma treatmentCancer Genomics and DiagnosticsProstate Cancer Treatment and ResearchLung Cancer Research StudiesHER2/EGFR in Cancer ResearchColorectal Cancer Treatments and StudiesLymphoma Diagnosis and Treatment

Frequently asked questions about Expert Review of Anticancer Therapy

Is Expert Review of Anticancer Therapy a predatory journal?

PubScope has no integrity flags on record for Expert Review of Anticancer Therapy: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Expert Review of Anticancer Therapy?

Expert Review of Anticancer Therapy is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.24.

Is Expert Review of Anticancer Therapy indexed in Scopus and Web of Science?

Expert Review of Anticancer Therapy is indexed in Web of Science, Scopus.

What is the aims and scope of Expert Review of Anticancer Therapy?